Capillary and Venous Blood Sampling Devices Market size is poised to cross USD 12.3 Billion by the end of 2035, observing nearly 7.2% growth rate from 2023 to 2035. In the year 2022, the industry size of capillary and venous blood sampling devices was USD 5.03 Billion. The demand for capillary and venous blood sampling devices is growing faster due to the increasing prevalence of diabetes cases globally. According to IDF, in 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is expected to rise to 643 million by 2030 and 783 million by 2045 worldwide.
In addition, there is a rapid increase in healthcare expenditure providing a driving factor to the capillary and venous blood sampling devices market. According to the data stated by the Centers for Disease Control (CDC), hospital care spending was USD 3,795 billion in the United States in 2019.
Base Year |
2022 |
Forecast Year |
2023-2035 |
CAGR |
7.2% |
Base Year Market Size (2022) |
USD 5.03 Billion |
Forecast Year Market Size (2035) |
USD 12.3 Billion |
Regional Scope |
|
Growth Drivers
Product (Capillary Blood Collection Devices, Venous Blood Collection Devices)
The capillary and venous blood sampling devices market from venous blood sampling devices segment is estimated to gain the largest market share of USD 7,836.6 million over the projected time frame. The segment's expansion can be attributable to the vast number of clinical trials with HSV-based viruses that are now underway. Thus, the main venous blood collection devices are tubes and vacutainer systems used for cancer, HIV/AIDS, and other blood testing which are fueling the expansion of the venous blood collection devices segment in the market. Furthermore, veins are favored over arteries and capillaries as they have thinner walls, and thus they are easier to puncture.
Device (Point-of-Care Testing, Central Testing)
Out of devices of capillary and venous blood sampling devices, the central testing segment is predicted to have a tremendous share in the upcoming years as the majority of blood tests are performed in the laboratories by different methods in order to result more accurate. They can process a large number of samples with high efficiency and automation, requiring less manual assistance. For instance, in 2021, among the more than 320,000 federally licensed laboratories in the United States, there were more than 329,000 laboratory specialists employed. In addition to the roughly 1 billion COVID-19 tests performed during the epidemic, an estimated 14 billion laboratory tests are ordered annually in the United States.
Our in-depth analysis of the market includes the following segments:
By Product |
|
By Device |
|
By Application |
|
By End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this Report
North American Market Statistics
The North American capillary and venous blood sampling devices market is projected to hold the largest market share of USD 5,040.2 Million in the year 2035. The region generated a revenue of USD 2,021.4 Million in 2022. The North American market for capillary and venous blood sampling devices is growing faster due to the rise in the prevalence of both communicable and non-communicable diseases, as well as other health-related problems such as cardiovascular disease. Also, there has been an advancement in the healthcare system, and the presence of market leaders in the region.
APAC Market Forecast
The Asia Pacific capillary and venous blood sampling devices market also grow with the highest CAGR of 7.8% by the end of 2035. The growth of the market can be attributed majorly to the demographic shifts brought on by an aging population and an uptick in government support for blood donation and sampling programs for routine healthcare checks across the region. The population of the Asia-Pacific region is growing older at a rate higher than any other part of the world. This means that 60 percent of the world's aging population now comprises individuals aged 60 or older, with 630 million people reaching this milestone. The market growth for capillary and venous blood sampling devices is supported by the region's rapidly aging population. In addition, the region's expanding healthcare spending and rising approvals of new capillary and venous blood sampling devices are also anticipated to boost the market growth during the forecast period.
European Market Analysis
The capillary and venous blood sampling devices market in the European region is predicted to have significant growth between 2023 and 2035, growing by a CAGR of 6.7 percent. The European market was valued at USD 1,477.1 Million in the year 2022. The surging trend of developing capillary and venous blood sampling devices by manufacturers in the region that are easy to use, so that they can be used by the patients at home.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increasing prevalence of cancer cases worldwide and increasing healthcare expenditure are the major factors driving the market growth.
Ans: The market is anticipated to attain a CAGR of 7.2% over the forecast period, i.e., 2023 – 2035.
Ans: The major players in the market are Shanghai Sunway Biotech Co., Ltd., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Medtronic Plc, Merck KGaA, Bio-Rad Laboratories, Inc. among others.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product, device, application, end user, and by region.
Ans: The venous blood sampling devices segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Ans: Stringent regulatory approval and product recall are estimated to be the growth-hindering factors for the market expansion.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future due to advanced healthcare system.
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?